Literature DB >> 26466611

ENDOCRINE DILEMMA: Managing menopausal symptoms after breast cancer.

John Eden1.   

Abstract

Managing the symptoms of menopause after a diagnosis of breast cancer offers some unique clinical challenges. For some women, vasomotor symptoms can be severe and debilitating, and hormone therapy is at least relatively contraindicated. Non-oestrogen therapies for hot flushes include SSRIs, clonidine, gabapentin and perhaps black cohosh extracts. Vulvovaginal atrophy can usually be alleviated by simple moisturizers, although some may need specialized physiotherapy such as vaginal dilators. In a small number, topical oestrogens may be the only treatment that works. The CO2 laser may be a novel, non-oestrogen therapy to alleviate this unpleasant symptom. Bone loss can be accelerated in some patients on AIs or those who had early menopause induced by chemotherapy.
© 2016 European Society of Endocrinology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26466611     DOI: 10.1530/EJE-15-0814

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  2 in total

1.  Incidence of menopausal symptoms in postmenopausal breast cancer patients treated with aromatase inhibitors.

Authors:  Dongsheng Hong; Ling Bi; Jun Zhou; Yinghui Tong; Qingwei Zhao; Jing Chen; Xiaoyang Lu
Journal:  Oncotarget       Date:  2017-06-20

2.  Analysis and Identification of Active Compounds from Gami-Soyosan Toxic to MCF-7 Human Breast Adenocarcinoma Cells.

Authors:  Mi-Yeon Jung; Chang-Seob Seo; Seon-Eun Baek; Jaemin Lee; Myoung-Sook Shin; Ki Sung Kang; Sullim Lee; Jeong-Eun Yoo
Journal:  Biomolecules       Date:  2019-07-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.